Stock Information
LB Pharmaceuticals Inc (LBRX)
Ticker Symbol: LBRX
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $827.15 mil
Piotroski score: 1
PE Ratio: N/A
EPS (TTM): -2.98
Revenue (TTM): $0.00 M
Dividend Yield: N/A
ROE: -25.91%
Latest News
-
LB Pharmaceuticals (LBRX) Stock Fair Value Rises As LB 102 Outlook Shifts
Sun, Oct 11, 2026 1:15 AM
-
LB Pharmaceuticals Presents New Preclinical Data Supporting LB-102’s Bimodal Mechanism of Action and Highlights Ongoing Late-Stage Clinical Development Programs at the 39th ECNP Congress
Sat, Oct 10, 2026 12:00 PM
-
LB Pharmaceuticals Reports Inducement Grants to New Employee Under Nasdaq Listing Rule 5635(c)(4)
Fri, Oct 9, 2026 8:42 PM
-
Canaccord Genuity Initiates Coverage On LB Pharmaceuticals with Buy Rating, Announces Price Target of $65
Fri, Oct 9, 2026 2:11 PM
-
LB Pharmaceuticals to Host In-Person and Virtual R&D Day on October 27, 2026: Advancing LB‑102 with a Focus on Schizophrenia Treatment
Tue, Oct 6, 2026 12:00 PM
-
Guggenheim Initiates Coverage On LB Pharmaceuticals with Buy Rating, Announces Price Target of $80
Tue, Oct 6, 2026 8:14 AM
Key Financials
Financial data not available
